A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation

Programmed cell death pathways play an important role in innate immune responses to infection. Activation of intrinsic apoptosis promotes infected cell clearance; however, comparatively little is known about how this mode of cell death is regulated during infections and whether it can induce inflammation. Here, we identify that the pro‐survival BCL‐2 family member, A1, controls activation of the essential intrinsic apoptotic effectors BAX/BAK in macrophages and monocytes following bacterial lipopolysaccharide (LPS) sensing. We show that, due to its tight transcriptional and post‐translational regulation, A1 acts as a molecular rheostat to regulate BAX/BAK‐dependent apoptosis and the subsequent NLRP3 inflammasome‐dependent and inflammasome‐independent maturation of the inflammatory cytokine IL‐1β. Furthermore, induction of A1 expression in inflammatory monocytes limits cell death modalities and IL‐1β activation triggered by Neisseria gonorrhoeae‐derived outer membrane vesicles (NOMVs). Consequently, A1‐deficient mice exhibit heightened IL‐1β production in response to NOMV injection. These findings reveal that bacteria can induce A1 expression to delay myeloid cell death and inflammatory responses, which has implications for the development of host‐directed antimicrobial therapeutics.

[1]  H. Sampath,et al.  Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. , 2022, Immunity.

[2]  Si Ming Man,et al.  Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway , 2022, Immunity.

[3]  Erinna F. Lee,et al.  Discovery, development and application of drugs targeting BCL-2 pro-survival proteins in cancer , 2021, Biochemical Society transactions.

[4]  J. Pearson,et al.  Evolutionary dynamics of multidrug resistant Salmonella enterica serovar 4,[5],12:i:- in Australia , 2021, Nature Communications.

[5]  D. Brownfield,et al.  Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity , 2021, Science Advances.

[6]  Thomas Naderer,et al.  Bacterial outer membrane vesicles and host cell death signaling. , 2021, Trends in microbiology.

[7]  Q. You,et al.  Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy. , 2021, European journal of medicinal chemistry.

[8]  Laura F. Dagley,et al.  The ubiquitylation of IL-1β limits its cleavage by caspase-1 and targets it for proteasomal degradation , 2021, Nature Communications.

[9]  J. Garlick,et al.  Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells. , 2021, Immunity.

[10]  L. Gangoda,et al.  Absence of pro-survival A1 has no impact on inflammatory cell survival in vivo during acute lung inflammation and peritonitis , 2021, Cell Death & Differentiation.

[11]  M. A. Wemyss,et al.  The diverse roles of RIP kinases in host-pathogen interactions , 2020, Seminars in Cell & Developmental Biology.

[12]  Jian Li,et al.  Mitochondrial dysfunction caused by outer membrane vesicles from Gram-negative bacteria activates intrinsic apoptosis and inflammation , 2020, Nature Microbiology.

[13]  K. E. Lawlor,et al.  RIP-roaring inflammation: RIPK1 and RIPK3 driven NLRP3 inflammasome activation and autoinflammatory disease. , 2020, Seminars in cell & developmental biology.

[14]  A. Strasser,et al.  Flexible Usage and Interconnectivity of Diverse Cell Death Pathways Protect against Intracellular Infection , 2020, Immunity.

[15]  L. Gangoda,et al.  The pro-survival Bcl-2 family member A1 delays spontaneous and FAS ligand-induced apoptosis of activated neutrophils , 2020, Cell Death & Disease.

[16]  S. Tait,et al.  Mitochondrial DNA in inflammation and immunity , 2020, EMBO reports.

[17]  T. Kaufmann,et al.  Impact of BH3-mimetics on Human and Mouse Blood Leukocytes: A Comparative Study , 2020, Scientific Reports.

[18]  P. Vogel,et al.  Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity–independent pyroptosis, apoptosis, necroptosis, and inflammatory disease , 2019, The Journal of experimental medicine.

[19]  M. Pasparakis,et al.  Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis , 2019, Nature.

[20]  Rohit Reja,et al.  Activity of caspase-8 determines plasticity between cell death pathways , 2019, Nature.

[21]  J. Mullikin,et al.  Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease , 2019, Nature.

[22]  L. Komuves,et al.  Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis , 2019, Nature.

[23]  Steven L Salzberg,et al.  Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype , 2019, Nature Biotechnology.

[24]  Kaiwen W. Chen,et al.  Extrinsic and intrinsic apoptosis activate pannexin‐1 to drive NLRP3 inflammasome assembly , 2019, The EMBO journal.

[25]  A. Lew,et al.  Macrophages, rather than DCs, are responsible for inflammasome activity in the GM-CSF BMDC model , 2019, Nature Immunology.

[26]  A. Letai,et al.  Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins , 2019, Nature Reviews Molecular Cell Biology.

[27]  Daniel S. Simpson,et al.  Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation , 2018, Journal of leukocyte biology.

[28]  A. Mócsai,et al.  Myeloid-Specific Deletion of Mcl-1 Yields Severely Neutropenic Mice That Survive and Breed in Homozygous Form , 2018, The Journal of Immunology.

[29]  Dhruv Chauhan,et al.  BAX/BAK-Induced Apoptosis Results in Caspase-8-Dependent IL-1β Maturation in Macrophages. , 2018, Cell reports.

[30]  Si Ming Man,et al.  The Mitochondrial Apoptotic Effectors BAX/BAK Activate Caspase-3 and -7 to Trigger NLRP3 Inflammasome and Caspase-8 Driven IL-1β Activation. , 2018, Cell reports.

[31]  D. Green,et al.  Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection , 2018, Proceedings of the National Academy of Sciences.

[32]  J. Bertin,et al.  Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death , 2018, Science.

[33]  S. Akira,et al.  Infection with flaviviruses requires BCLXL for cell survival , 2018, PLoS pathogens.

[34]  Gordon K Smyth,et al.  The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads , 2018, bioRxiv.

[35]  M. Gaestel,et al.  Differentiated macrophages acquire a pro-inflammatory and cell death–resistant phenotype due to increasing XIAP and p38-mediated inhibition of RipK1 , 2018, The Journal of Biological Chemistry.

[36]  J. Klco,et al.  TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation , 2018, The Journal of experimental medicine.

[37]  G. Dougan,et al.  Outer membrane vesicles from Neisseria gonorrhoeae target PorB to mitochondria and induce apoptosis , 2018, PLoS pathogens.

[38]  Thomas Naderer,et al.  Targeting apoptosis pathways in infections , 2018, Journal of leukocyte biology.

[39]  D. Russell,et al.  Oxysterol Restraint of Cholesterol Synthesis Prevents AIM2 Inflammasome Activation , 2017, Cell.

[40]  T. Aittokallio,et al.  Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins , 2017, Viruses.

[41]  A. Oberst,et al.  Mitochondrial permeabilisation engages NF-κB dependent anti-tumour activity under caspase deficiency , 2017, Nature Cell Biology.

[42]  A. Strasser,et al.  The combination of reduced MCL-1 and standard chemotherapeutics is tolerable in mice , 2017, Cell Death and Differentiation.

[43]  D. Vaux,et al.  XIAP Loss Triggers RIPK3- and Caspase-8-Driven IL-1β Activation and Cell Death as a Consequence of TLR-MyD88-Induced cIAP1-TRAF2 Degradation. , 2017, Cell reports.

[44]  D. Green,et al.  Caspase‐8: regulating life and death , 2017, Immunological reviews.

[45]  D. Bachovchin,et al.  Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages. , 2017, Cell chemical biology.

[46]  A. Strasser,et al.  Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment , 2017, Cell Death and Differentiation.

[47]  E. Miao,et al.  Programmed cell death as a defence against infection , 2017, Nature Reviews Immunology.

[48]  D. Vaux,et al.  Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner , 2017, Proceedings of the National Academy of Sciences.

[49]  D. Vaux,et al.  Cycloheximide Can Induce Bax/Bak Dependent Myeloid Cell Death Independently of Multiple BH3-Only Proteins , 2016, PloS one.

[50]  M. Kaparakis-Liaskos,et al.  Bacterial membrane vesicles: Biogenesis, immune regulation and pathogenesis , 2016, Cellular microbiology.

[51]  A. Strasser,et al.  The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models , 2016, Nature.

[52]  A. Oberst,et al.  Activity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell Death , 2016, PLoS pathogens.

[53]  G. Häcker,et al.  Anti-apoptotic Bcl-XL but not Mcl-1 contributes to protection against virus-induced apoptosis , 2016, Cell Death and Disease.

[54]  M. Kelliher,et al.  CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN. , 2016, Cell reports.

[55]  V. Dixit,et al.  Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.

[56]  Stefan P. Glaser,et al.  The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia , 2016, Science Translational Medicine.

[57]  Jonathan L. Schmid-Burgk,et al.  Human Monocytes Engage an Alternative Inflammasome Pathway. , 2016, Immunity.

[58]  Stefan P. Glaser,et al.  Eliminating Legionella by inhibiting BCL-XL to induce macrophage apoptosis , 2016, Nature Microbiology.

[59]  J. Vier,et al.  The anti-apoptotic Bcl-2 family protein A1/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK/STAT signaling , 2016, Cell Death and Disease.

[60]  P. Brož,et al.  Caspase‐11 activates a canonical NLRP3 inflammasome by promoting K+ efflux , 2015, European journal of immunology.

[61]  S. Kummerfeld,et al.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.

[62]  T. Cai,et al.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death , 2015, Nature.

[63]  Maryam Rashidi,et al.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL , 2015, Nature Communications.

[64]  K. Schroder,et al.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases , 2015, Nature Medicine.

[65]  P. Czabotar,et al.  Characterisation of a novel A1-specific monoclonal antibody , 2014, Cell Death and Disease.

[66]  D. Vaux,et al.  Mitochondrial apoptosis is dispensable for NLRP3 inflammasome activation but non‐apoptotic caspase‐8 is required for inflammasome priming , 2014, EMBO reports.

[67]  A. Strasser,et al.  XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. , 2014, Cell reports.

[68]  D. Vaux,et al.  PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK 1-and RIPK 3-dependent manner , 2014 .

[69]  J. Vince,et al.  Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria? , 2014, Biochimica et biophysica acta.

[70]  L. Komuves,et al.  Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis , 2014, Science.

[71]  G. Smyth,et al.  voom: precision weights unlock linear model analysis tools for RNA-seq read counts , 2014, Genome Biology.

[72]  D. Zamboni,et al.  Subversion of inflammasome activation and pyroptosis by pathogenic bacteria , 2013, Front. Cell. Infect. Microbiol..

[73]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[74]  K. Schroder,et al.  AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC , 2013, Cell Death and Differentiation.

[75]  A. Mildner,et al.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. , 2013, Immunity.

[76]  Andrew Kovalenko,et al.  Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. , 2013, Immunity.

[77]  L. Lam,et al.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets , 2013, Nature Medicine.

[78]  D. Green,et al.  Cutting Edge: FAS (CD95) Mediates Noncanonical IL-1β and IL-18 Maturation via Caspase-8 in an RIP3-Independent Manner , 2012, The Journal of Immunology.

[79]  Moshe Arditi,et al.  Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. , 2012, Immunity.

[80]  J. Tschopp,et al.  Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. , 2012, Immunity.

[81]  R. Xavier,et al.  CASPASE 8 inhibits programmed necrosis by processing CYLD , 2011, Nature Cell Biology.

[82]  R. Strasser,et al.  Generation of Mature Murine Monocytes from Heterogeneous Bone Marrow and Description of Their Properties , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[83]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[84]  Guy S. Salvesen,et al.  Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis , 2011, Nature.

[85]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[86]  J. Opferman,et al.  Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function. , 2009, Blood.

[87]  Xiaodong Wang,et al.  TNF-α Induces Two Distinct Caspase-8 Activation Pathways , 2008, Cell.

[88]  S. Fesik,et al.  ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. , 2008, Cancer research.

[89]  Yide Mei,et al.  Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. , 2007, Cellular signalling.

[90]  You-Wen He,et al.  The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. , 2007, Blood.

[91]  C. Scott,et al.  The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. , 2006, Cancer cell.

[92]  I. Berberich,et al.  The Stability and Anti-apoptotic Function of A1 Are Controlled by Its C Terminus* , 2006, Journal of Biological Chemistry.

[93]  C. Gélinas,et al.  Constitutive proteasome-mediated turnover of Bfl-1/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor , 2005, Cell Death and Differentiation.

[94]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[95]  D. Vaux,et al.  Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die , 2004, The Journal of cell biology.

[96]  J. Trapani,et al.  A new quantitative assay for cytochrome c release in apoptotic cells , 2003, Cell Death and Differentiation.

[97]  K. Roth,et al.  Mcl-1 deficiency results in peri-implantation embryonic lethality. , 2000, Genes & development.

[98]  P. Schotte,et al.  Stimulation of Toll-like receptor 3 and 4 induces interleukin-1 (cid:2) maturation by caspase-8 , 2008 .

[99]  S. Janssens,et al.  Brief Definitive Report Stimulation of Toll-like Receptor 3 and 4 Induces Interleukin-1 ␤ Maturation by Caspase-8 , 2022 .